It has been evident that many factors such as oxidized low-density lipoprotein (ox-LDL), angiotensin II (Ang II), and interleukin-6 (IL-6) can impair the barrier and secretion functions of VECs in different cardiovascular diseases, leading to an acceleration of disease progression [4]. The gene discussed is IL6; the disease is cardiovascular disorder.